Navigation Links
Evofem Announces Strategic Alliance with WomanCare Global
Date:3/4/2013

SAN DIEGO, March 4, 2013 /PRNewswire/ -- Evofem announced today that it has entered into a strategic alliance with WomanCare Global.  Through this alliance, WomanCare Global will provide sales, marketing and global distribution for a selection of Evofem's products, including Softcup™ and Amphora®.  Additionally, Saundra Pelletier , founding CEO of WomanCare Global, has been named the new CEO of Evofem Inc.

(Logo: http://photos.prnewswire.com/prnh/20130304/CG70327LOGO)

Amphora, a vaginal gel approved by the FDA in 2004 as a lubricant, is currently undergoing the largest global clinical trial to date of a non-hormonal contraceptive vaginal gel. Through various studies, Amphora has shown potential to be effective in protecting against sexually transmitted infections (STIs) including HIV.  Softcup is a personal care alternative to tampons and sanitary pads that can be worn for up to 12 hours.  It's body-friendly, in both disposable and reusable options, with no drying cotton or rayon fibers and no link to Toxic Shock Syndrome (TSS).   

"Our strategic alliance with WomanCare Global is a momentous achievement for Evofem," said Joseph Pike , Evofem LLC's Chief Executive Officer. "Having developed a distribution supply chain into over 100 countries, WomanCare Global operates as a sustainable not-for-profit that will allow us to provide our products and services to women and girls throughout the world, especially to those who live in areas where their reproductive healthcare needs are underserved." 

"We are so pleased to partner with Evofem to create global access to Softcup and contribute to the commercialization plans for Amphora," said WomanCare Global CEO Saundra Pelletier .  "These exciting reproductive health products offer women and girls with an innovative, new contraceptive choice and a safe way to manage their menses."

About Evofem
Evofem LLC is a privately held company that brings advanced prescription and consumer products to global markets addressing the unmet needs of women, men and families. Through its subsidiaries, Evofem Inc. and Cosmederm Bioscience, Evofem discovers, develops and commercializes prescription and over-the-counter products, in the areas of feminine care, contraception, dermatology, pain management, and the prevention of sexually transmitted infections, including HIV/AIDs. Evofem was founded in 2000 and is based in San Diego, California.

About WomanCare Global
Meeting the vast unmet demand for family planning and enabling women to choose whether and when they'll have children requires investing in cost-effective, innovative approaches. WomanCare Global's mission is to provide affordable access to high-quality reproductive health products for women and girls around the world through a sustainable supply chain, empowering them to make and act on safe choices.  WomanCare Global applies industry-based expertise to effectively address the entire supply chain ─ from manufacturing through the timely, reliable delivery of high-quality products and care. This total-market approach positions WomanCare Global strongly for large-scale, sustainable impact.


'/>"/>
SOURCE Evofem
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. DMH International Announces Agreement with MyDICOM and ChangZhou Wealth Information & Technology Co. Ltd
2. Hill-Rom Announces Second Quarter 2013 Dividend
3. NeuroDerm Announces Positive Results of a Phase I Study of ND0612 for the Treatment of Parkinsons Disease
4. Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Affymax, Inc.
5. PDL BioPharma Announces Fourth Quarter and Full Year 2012 Financial Results
6. Hospira Announces Executive Changes
7. Citiustech Announces Launch of Bi-Clinical Cloud and App-Based Architecture
8. DMH International Announces FDA Approval of TouchPACS
9. ADVENTRX Announces Corporate Name Change To "Mast Therapeutics, Inc."; Ticker Symbol Change To "MSTX"
10. DelMar Pharmaceuticals Announces Appointment of John K. Bell to Board of Directors
11. Orexigen Therapeutics Announces Webcast of Upcoming Presentation at the Cowen & Co. Annual Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/15/2017)... , Aug. 15, 2017 AccuGenomics, Inc., a ... , today announced that the company has provided an ... of North Carolina at Chapel Hill and to Qura ... to characterize and quantify HIV reservoir and viral expression ... intervention. The HIV Cure Center is a joint initiative ...
(Date:8/8/2017)... Aug. 8, 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), a ... reports its financial results for the second quarter ended ... the second quarter 2017 and to date: ... development programs for the Company,s lead project, BL-8040: ... study with BL-8040 as novel stem cell mobilization treatment ...
(Date:8/7/2017)... 7, 2017  Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation,s ... ended June 30, 2017.  All comparisons, unless otherwise noted, are ... Second Quarter 2017 Highlights include: ... million, an increase of 3.5% Total prescriptions ... margin of 7.5% versus 7.6% Gross ...
Breaking Medicine Technology:
(Date:8/18/2017)... ... August 18, 2017 , ... With over 16,000 ... bioidentical hormone replacement therapy and integrative medicine, has become a frontrunner for people ... such as menopause, andropause, thyroid disorder and adrenal insufficiencies. , Founded in ...
(Date:8/18/2017)... ... August 18, 2017 , ... 800response, the ... monitoring solutions, announced today the launch of a redesigned corporate website, 800response.com ... aesthetic, fully responsive design, and an enhanced search directory for businesses and advertising ...
(Date:8/18/2017)... (PRWEB) , ... August 18, 2017 , ... “Beyond Our ... fulfilled life. “Beyond Our Imaginations: The Infinite God” is the creation of published author, ... across the country. , Lawrence shares, “The problem with becoming a greater man of ...
(Date:8/18/2017)... ... 18, 2017 , ... “Prompted By Love”: a love story thrown into doubt ... Nettles. Author Mary P. Nettles has devoted her life to ministry since the ... lifelong desire to write was, however, not fulfilled until 2014 when "The Color of ...
(Date:8/17/2017)... ... August 17, 2017 , ... Shared leadership between physicians ... effective, very effective, or effective by 85% of respondents, according to the recent ... Reports are based on surveys of the NEJM Catalyst Insights Council, a qualified ...
Breaking Medicine News(10 mins):